ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,637Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 1269

$1.11M Total Retail Price of All Prescriptions

Rank: 13 out of 1269

493 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 493 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

3% of this provider’s 493 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 18,239 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 743 719 1 1
METOPROLOL TARTRATE 740 677 2 6
LEVOTHYROXINE SODIUM 661 611 3 4
FUROSEMIDE 624 605 4 5
DONEPEZIL HCL 562 539 5 22
AMLODIPINE BESYLATE 558 521 6 2
MIRTAZAPINE 451 432 7 24
WARFARIN SODIUM 439 422 8 12
SIMVASTATIN 350 311 9 3
TRAMADOL HCL 329 282 10 16
LANTUS 314 271 11 39
NAMENDA 304 292 12 38
CITALOPRAM HBR 300 293 13 21
SERTRALINE HCL 262 236 14 23
OMEPRAZOLE 255 241 15 8
RISPERIDONE 249 243 16 43
ATORVASTATIN CALCIUM 238 230 17 7
PANTOPRAZOLE SODIUM 238 229 17 18
POLYETHYLENE GLYCOL 3350 233 198 19 50
GABAPENTIN 223 195 20 17
HYDROCHLOROTHIAZIDE 213 196 21 10
QUETIAPINE FUMARATE 193 184 22 53
METFORMIN HCL 186 180 23 9
DIVALPROEX SODIUM 183 166 24 54
TRAZODONE HCL 182 174 25 36
CARBIDOPA-LEVODOPA 173 173 26 78
CARVEDILOL 172 171 27 29
PRAVASTATIN SODIUM 164 155 28 11
KLOR-CON M20 162 145 29 60
LIDODERM 160 159 30 56
SULFAMETHOXAZOLE-TRIMETHOPRIM 159 151 31 84
CLOPIDOGREL 159 141 31 32
NOVOLOG 158 133 33 82
SANTYL 155 151 34 101
IPRATROPIUM-ALBUTEROL 154 124 35 86
ALENDRONATE SODIUM 153 131 36 28
ATENOLOL 152 151 37 14
TAMSULOSIN HCL 142 142 38 31
METOPROLOL SUCCINATE 141 129 39 13
POTASSIUM CHLORIDE 137 137 40 26
GENERLAC 135 132 41 216
MUPIROCIN 126 114 42 232
CIPROFLOXACIN HCL 124 108 43 66
CYMBALTA 119 113 44 70
DIOVAN 116 113 45 35
CLONIDINE HCL 116 106 45 51
OXYCODONE-ACETAMINOPHEN 112 103 S2 47 44
LACTULOSE 106 104 48 67
PLAVIX 106 99 48 47
RANITIDINE HCL 106 82 48 27
ABILIFY 104 93 51 169
OLANZAPINE 102 101 52 89
ADVAIR DISKUS 102 98 52 46
HYDRALAZINE HCL 101 96 54 48
PREDNISONE 100 98 55 45
SEROQUEL 100 98 55 104
HALOPERIDOL 98 85 57 133
LEVOFLOXACIN 94 81 58 75
LOSARTAN POTASSIUM 92 92 59 15
LEVETIRACETAM 92 88 59 55
DIGOXIN 90 90 61 62
BUSPIRONE HCL 90 87 61 135
ISOSORBIDE MONONITRATE ER 89 89 63 63
TRAVATAN Z 86 86 64 187
BUDESONIDE 84 72 65 244
LATANOPROST 83 74 66 143
ALBUTEROL SULFATE 82 74 67 88
TIMOLOL MALEATE 76 67 68 293
ESCITALOPRAM OXALATE 76 74 68 58
IPRATROPIUM BROMIDE 74 38 70 127
PAROXETINE HCL 73 68 71 71
SPIRIVA 73 70 71 64
MELOXICAM 70 66 73 68
VENLAFAXINE HCL ER 70 46 73 140
AMIODARONE HCL 69 69 75 166
DOXAZOSIN MESYLATE 69 55 75 117
TRAMADOL HCL-ACETAMINOPHEN 69 69 75 164
PRADAXA 68 68 78 281
NYSTATIN 68 64 78 119
FINASTERIDE 65 65 80 112
BRIMONIDINE TARTRATE 61 61 81 205
HYDROCODONE-ACETAMINOPHEN 61 54 S3 81 20
AMOX TR-POTASSIUM CLAVULANATE 55 55 83 110
OXYBUTYNIN CHLORIDE ER 55 46 83 130
FAMOTIDINE 54 53 85 85
NIFEDIPINE ER 52 51 86 65
KETOCONAZOLE 51 47 87 203
CEPHALEXIN 50 50 88 113
BENZTROPINE MESYLATE 50 50 R 88 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.